Using this humanized in vivo liver model, our aim was to determine whether and to what degree the mutant enzyme could correct the metabolic deficiency and hepatotoxicity in Fah−/− mice. Here, FAH is linked to hyperinsulinemic hypoglycemia, familial, 4.